These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18601867)

  • 1. [An unexpected role for arginine vasopressin as an innate immunity inhibitor during renal bacterial infection].
    Chassin C; Vandewalle A
    Med Sci (Paris); 2008; 24(6-7):564-6. PubMed ID: 18601867
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of antidiuretic hormone, indomethacin and naproxen on prostaglandin synthesis of experimentally infected and healthy kidneys.
    Túri S; Pulkkinen M; Kaihola HL; Kangas L; Nieminen L
    Int Urol Nephrol; 1982; 14(3):195-200. PubMed ID: 6761298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1-Desamino 8-D arginine-vasopressin in the diagnosis and treatment of central diabetes insipidus in a patient after cadaveric renal transplantation.
    Zeller WP; Heidkamp K; Hurley RM
    Transplant Proc; 1985 Aug; 17(4):2007-8. PubMed ID: 3895644
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
    Kobayashi I; Takahashi H; Sanada M; Takahashi K; Hattori A; Ito M; Sakuragawa N; Shibata A; Shinada S; Tsukada T
    Rinsho Ketsueki; 1979 Apr; 20(4):364-71. PubMed ID: 312954
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of von Willebrand's disease--successful application of 1-deamino-8-D-arginine vasopressin (DDAVP) to ovarian bleeding].
    Shiraishi K; Ebata H; Sato K; Tanaka M; Nouno R; Mashiko N; Yamaguchi G; Kubo Y; Tanikawa K; Ide K
    Rinsho Ketsueki; 1983 Dec; 24(12):1674-9. PubMed ID: 6608600
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical application of 1-deamino-8-D-arginine vasopressin to mild hemophilia A (author's transl)].
    Kobayashi I; Takahashi H; Takahashi K; Ito M; Sakuragawa N; Shibata A; Matsuoka M; Shinada S; Tsukada T
    Rinsho Ketsueki; 1978 Dec; 19(12):1614-21. PubMed ID: 739615
    [No Abstract]   [Full Text] [Related]  

  • 8. Arginine vasopressin versus desmopressin for the treatment of diabetes insipidus in the brain dead organ donor.
    Debelak L; Pollak R; Reckard C
    Transplant Proc; 1990 Apr; 22(2):351-2. PubMed ID: 2326913
    [No Abstract]   [Full Text] [Related]  

  • 9. 1-Deamino-8-D-arginine vasopressin as a therapy for the bleeding diathesis of renal failure.
    Watson AJ; Keogh JA
    Am J Nephrol; 1984; 4(1):49-51. PubMed ID: 6731500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Deamino-8-d-arginine vasopressin (DDAVP): a potential new treatment for the bleeding diathesis of acute renal failure.
    Watson AJ; Keogh JA
    Pharmatherapeutica; 1984; 3(9):618-22. PubMed ID: 6728864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin for hemophilia and other coagulation disorders.
    Med Lett Drugs Ther; 1984 Aug; 26(669):82. PubMed ID: 6332266
    [No Abstract]   [Full Text] [Related]  

  • 12. [DDAVP: alternative therapy in moderate pathology of Factor VIII/von Willebrand].
    Vicente V; Alberca I; Moraleda JM; López Borrasca A
    Sangre (Barc); 1983; 28(4):531-2. PubMed ID: 6606856
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of diabetes insipidus with a synthetic analog of vasopressin during pregnancy.
    Sack J; Friedman E; Katznelson D; Frenkel Y
    Isr J Med Sci; 1980 May; 16(5):406-7. PubMed ID: 7399872
    [No Abstract]   [Full Text] [Related]  

  • 14. Desmopressin: a new drug for the treatment of bleeding disorders.
    Haas D; Nace GS
    J Nephrol Nurs; 1985; 2(2):72-3. PubMed ID: 3845983
    [No Abstract]   [Full Text] [Related]  

  • 15. [The position of a vasopressin derivative ("DDAVP") in the treatment of haemophilia A (author's transl)].
    Blättler W; Jacky E; Müller M; Graf M; Meili E
    Ther Umsch; 1979 Apr; 36(4):330-3. PubMed ID: 377557
    [No Abstract]   [Full Text] [Related]  

  • 16. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.
    Mannucci PM; Remuzzi G; Pusineri F; Lombardi R; Valsecchi C; Mecca G; Zimmerman TS
    N Engl J Med; 1983 Jan; 308(1):8-12. PubMed ID: 6401193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of DDAVP (desmopressin) in primary nocturnal enuresis].
    Bernasconi S; Monti G
    Minerva Pediatr; 1982 Feb; 34(3):131-4. PubMed ID: 7078535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pseudoresistance to DDAVP in diabetes insipidus].
    Radó J; Pató E; Czigner J; Fáber K
    Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vasopressin on memory following electroconvulsive therapy.
    Lerer B; Zabow T; Egnal N; Belmaker RH
    Biol Psychiatry; 1983 Jul; 18(7):821-4. PubMed ID: 6615939
    [No Abstract]   [Full Text] [Related]  

  • 20. [DDAVP in the treatment of nocturnal enuresis in children].
    Franchini F; Calzolari C; Merli L
    Minerva Pediatr; 1980 Nov; 32(21):1255-7. PubMed ID: 7219365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.